Tag | Content |
---|
EnhancerAtlas ID | HS105-74803 |
Organism | Homo sapiens |
Tissue/cell | IMR90 |
Coordinate | chr7:101928550-101931370 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
KLF16 | MA0741.1 | chr7:101930020-101930031 | GGGGGCGGGGC | - | 6.02 | KLF16 | MA0741.1 | chr7:101930056-101930067 | GGGGGCGGGGC | - | 6.02 | KLF16 | MA0741.1 | chr7:101930081-101930092 | GGGGGCGGGGC | - | 6.02 | KLF16 | MA0741.1 | chr7:101930111-101930122 | GGGGGCGGGGC | - | 6.02 | KLF16 | MA0741.1 | chr7:101929568-101929579 | GGGGGCGTGGT | - | 6.14 | KLF5 | MA0599.1 | chr7:101930021-101930031 | GGGGCGGGGC | - | 6.02 | KLF5 | MA0599.1 | chr7:101930057-101930067 | GGGGCGGGGC | - | 6.02 | KLF5 | MA0599.1 | chr7:101930082-101930092 | GGGGCGGGGC | - | 6.02 | KLF5 | MA0599.1 | chr7:101930112-101930122 | GGGGCGGGGC | - | 6.02 | NHLH1 | MA0048.2 | chr7:101929959-101929969 | CGCAGCTGCG | + | 6.02 | NHLH1 | MA0048.2 | chr7:101930365-101930375 | CGCAGCTGCG | + | 6.02 | NHLH1 | MA0048.2 | chr7:101929959-101929969 | CGCAGCTGCG | - | 6.02 | NHLH1 | MA0048.2 | chr7:101930365-101930375 | CGCAGCTGCG | - | 6.02 | SP1 | MA0079.4 | chr7:101930019-101930034 | CGGGGGCGGGGCCTG | - | 6.11 | SP1 | MA0079.4 | chr7:101930055-101930070 | AGGGGGCGGGGCCAG | - | 6.57 | SP2 | MA0516.2 | chr7:101930054-101930071 | GAGGGGGCGGGGCCAGG | - | 6.09 | SP3 | MA0746.2 | chr7:101930080-101930093 | GGGGGGCGGGGCC | - | 6.11 | SP3 | MA0746.2 | chr7:101929567-101929580 | AGGGGGCGTGGTG | - | 6.29 | SP4 | MA0685.1 | chr7:101930053-101930070 | GGAGGGGGCGGGGCCAG | - | 7.25 | SP8 | MA0747.1 | chr7:101929567-101929579 | AGGGGGCGTGGT | - | 6.52 | Zfx | MA0146.2 | chr7:101930020-101930034 | GGGGGCGGGGCCTG | + | 6.19 |
|
| Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
SE_58693 | chr7:101922324-101974102 | Ly1 | SE_60412 | chr7:101921972-101976670 | DHL6 | SE_61924 | chr7:101916815-101972690 | Toledo |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 3 | Chromosome | Start | End |
chr7 | 101929153 | 101929600 | chr7 | 101929978 | 101930313 | chr7 | 101929501 | 101929660 |
|
Enhancer Sequence | TTAGTCCACC GCGGGTCAGG CTCTCCCCTC TCCCGGGAGG GTGGAGACCA CAACCAGGCC 60 ATGTATGGAG CTTCCCTTTC TCCCACTCTC GGGCACCCCC TCCTCCCCCT TCCCGGCCTC 120 ATTCATAGGT GTCCTGGTTC CCAACCAGGC GTGCAGGCCT GTGTGCAGCT CCGATCGAGG 180 GCTGGCCCAC TGCCGAAGCT TTCATTAAAG TGTCTGCTGG CCTGGTCCTG CGGAGGGAAC 240 AGAGCCGAGA TGTGGGGCAG GGAAGGGGTC TGCCTGTCTT CCGTGCCCCC GTGGAGGGCA 300 GCACCGGGGT TTTGGGCAGC AGGTGAAGGC TCTGTCCCCT CCACCTTCAA CTCTGGAAGC 360 CCCACCTTTC CATCCCTAAG AAGGGTTTGA TAAAAACCCT TGTCTGTAAA TTAGAGATGG 420 GAAATGGCTC TGGGAAAAGT CAGAGGTCAG TTTGGGCCCG GGAGGGCGAC AGATGGAGGC 480 AGCTCCGGCT GGCAAGGAGA CCAGGACAGA ACTGCCAGAG GTGGGGGCAG GGGACAAGGA 540 GGGAGATGAG GGGAGAAGAC ACCCAGGGGT CCCCCCCTGC TATCTCCAGG AGCAAGACTA 600 CTCTCTTCTC TGAGCGGCCC TTTCCACACC TCTGCCCCCA CCGAAGCCCT CCCTCCCCTC 660 TCAGACCCCT TCCAGGCCTG CTGAGCCCCC TGCACCTCTT TCAGGAAGCC TCCCAGAGCC 720 CCCGCGCCGT GCCCTCAGCA CCAGGGGTCA GGCTACAAAT GCCCCGCAAA GCCCAGCGGG 780 ACTGTTTCCT CAGCCCCACT GGTCTCTGCC CTAAAGCAGG CGAGTTCTGG AGCCAGGCAG 840 GGGTGAGGAA GGTGCCAGGG TTGTGGCCCC TCATCGCCCC TCTATGATCT CTGACACCTC 900 TCCGGGTGGC ATCAGGCCCC CATCACAGCG AAGGCTGGGT GGTGGGGGCA CTGCGCTCAG 960 GGGGGCCGTC CCGCCCTGTG GCCCGGGGGC GATTTCCCGC ACCGGAGGGC TGCAGGGAGG 1020 GGGCGTGGTG GCGCCCTCGA GATTTATGAG AACCAGGCGT CGACTTCCTC CGTTGCGACA 1080 TCCAGGCCTC CTCCAGGCTC CCATTGTCCC TGCTGCGGAG AGTCTGGCCA CAGCGGCGGC 1140 TCCCGCGAAG CACCCGTCAG CGAGGGGCGC TTCGAGGGCG TCCGCGTCCC ATACACCCGC 1200 CACGCAGGAC ATTCCCCCGG CCCCACGCTC CGCGCTCCCG GGGCCACCAC CACCGCGGGC 1260 TCGAGGGGTG GCCTCCACGA GGAGGAGTGG GAGTCCCGCG CCTGGCCTGG GGCCGGCTCG 1320 GCGACATGGG GACCCCCGCC CAGATGGGGC GACTCGGAGC CGGCTCCTAA CCCCTCTCTC 1380 CGGGCCCCAG GACCGGGCAG TCTCGGCACC GCAGCTGCGG GGAGCCAGCA AGCACCGGCC 1440 ACCGGCGCCG CTCGGGCTCC GCGGATGGCC GGGGGCGGGG CCTGAGCGGC GCAAGTGGGG 1500 GCGGGAGGGG GCGGGGCCAG GACGCGCGAG GGGGGGCGGG GCCGGGGCTC GCGGCGGGGG 1560 CGGGGGCGGG GCCGGGGCCG GGAGGCGCGC GCCTCGCGGG CGGGGGGCGC GCCGCGCTGG 1620 GCTGGGCTTG GAGCGCGCGG AGCTCGGCTG CCAGAGAGCC GCGCGGGGGA CGCGCCGGGA 1680 CCGCGAGGAG CGCAGGAGCC TTCGAGGCGG TGAACGAGGG AGGGAGCCCA GTCCGCCGCG 1740 GGCCATGAGC CACCGGGCCC GGGGAGCCCG GCCGCGGTCC GGGCAGCGCT CAGCCGGCGC 1800 CCCAGCCCGC TCGGCCGCAG CTGCGCGCCT GTAGGTATGG CCTCCTTATA CCCAGTTCCT 1860 CGCTCCCTGG TCCTTCCCCC GGGACCCCTG TCTGTCCCCG GGGACGTGCG CTGTGTGCGC 1920 ACCGCTGCCC GAAGGAGAGC GGCCGCACGC GCCTTGGTCC GCGCGTGTCG TCTTTGTGTG 1980 CGCGGGTGGG AGGGAGGAGG GCGCGCGAGG GAGGGGAGGC GCCCCCGGCT GGGATCTGCT 2040 CCCCGATCCC CATCCCGGGC GGGGCGGGGA GCCGCTGGAG GGGCCGAGCC GCCTCTGGAG 2100 CAGCTGCGCC CCCGCCCCCT GCTAGGGCCC CGGCCGGGTA GTGGGGCGAG AGCAGCCGGG 2160 TCCTTAGAGG AGGGGTCTCT GGTTGGGGGA AGGGGTGCCC AGGTCTCTTC CCTACGCTGG 2220 GAGCGCTGGG AGGGGGCGTC AACCTAGAAT GAGGGTGAGG GCCACGGGAT GGGATCGGGG 2280 AGGACCTCCT CCAGGCCACA GGCACGCCCT CCCTTTGGCC CAGGCCCCCC TTTCTCGACC 2340 TGCCCAGCCG GGGAGCTCCC CGGAGCCCCC GATTGCCGGG AGGATCGTGG AGGGTGCCCA 2400 AGAGGCCGGC GCCTTTAAGA AGGGGCGGGT TCGTGCCCTC CATTCAGGCC CTTGGGCCTC 2460 GGCCATTGAT GAACCTGCGG GCTGCGCGGG CCGGAACCGC GCCAGCCCAG CGGGCTGAAG 2520 CCGGGCAGAG GCAGGGACGC ATCCTGGCCC CCTGCAGCCC CGAAGTGGGG GCCTTCAGGG 2580 AGGGAAGTCT GCAGTGACTG GAGCCTCTCA GGAGCCACGC AAGGCAGACC GGGCAGCCCC 2640 AGGCGAGACT CTGAACACGA ATAAGCCAGG ATCTACGTGC ACTTCGAGCT AGTGCAAGGG 2700 AGAGCCTCAG GCTAGGCTGT CAGACCTGGG TGGAGCCCTA CCAATGCCCC CGAGCCAACA 2760 TCACCTACCC TGTAAAATGG GATGGTGCTG CCTGCCTCCT GGCTAAGGGA CCGGCAACTC 2820
|